Nano-X Imaging Ltd. · Stock award · Ordinary Shares

What does this filing report?

An SEC Form 4 filing for Nano-X Imaging Ltd. records a stock award involving Ordinary Shares on October 14, 2026. The reported quantity was 28,283. The filing date is October 14, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Filing footnotes & remarks

F1

The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.

F2

The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028-- subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.

F3

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

F4

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).

F5

The options reported in this row were granted to the Reporting Person by the Issuer on September 30, 2021 and are fully vested and exercisable as of the date of this report.

F6

The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.

F7

The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.